THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder
meeting. Please follow the instructions on the reverse side to vote on these important matters. The proxy materials are available to you on the Internet. You may view these materials online at www.proxyvote.com or request a paper or email copy (see
reverse side). We encourage you to access and review all of the important information contained in the proxy materials before voting. Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click
“Delivery Settings”.
Voting Items Board Recommends V35392-P02299-Z86684 1. Election of Directors: 1a. David M. Cordani
For 1b. William J. DeLaney
For 1c. Eric J. Foss
For 1d. Retired Maj. Gen. Elder Granger, M.D.
For 1e. Neesha Hath
For 1f. George Kuria
For 1g. Kathleen M. Mazzarella
For 1h. Mark B. McClellan, M.D., Ph.D
For 1i. Philip O. Ozuah, M.D., Ph.D.
For 1j. Kimberly A. Ross
For 1k. Eric C. Wiseman
For 1l. Donna F. Zarcone
For 2. Advisory approval of The Cigna Group’s executive compensation.
For 3. Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group’s independent
registered public accounting firm for 2024.
For 4. Shareholder proposal - Improve the shareholder right to call a special shareholder meeting
Against 5. Shareholder proposal - Report to shareholders on risks created by the The Cigna Group’s diversity,
equity, and inclusion efforts.
Against NOTE: Such other business as may properly come before the meeting or any postponements or
adjournments thereof. Our board has fixed the close of business on March 5, 2024 as the record date for the determination of shareholders entitled to notice of, and to vote at, the meeting and any adjournments thereof. A list of shareholders will
be made available to shareholders during ordinary business hours for a period of at least ten days ending on the day before the meeting date at www.virtualshareholdermeeting.com/CI2024.